Skip to main content

vericiguat

Generic: VERICIGUAT·Brand: VERQUVO, Verquvo

vericiguat: 3 clinical trials tracked.

vericiguat evidence translation

What we can confirm

3 tracked trials

No verified listed company relationship

What it means

AI will separate confirmed drug evidence from unknown company context.

What to watch

Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected

Prepared research question

What is verified about vericiguat, and what remains unknown?

Run cited research

Traceable citations · Unknowns marked

See linked entities and source evidence2 indications · 0 study sponsors

Related indications

Study sponsors

No additional listed-company sponsor is linked.

Clinical Trial Registry Records (3)

Vericiguat for the Inhibition of Calcific Aortic Valve Stenosis Progression: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial (VERIFICATION Study)

NCT07715279Registry updated 2026-07-21·Phase 2
Not yet recruiting

Primary endpoint: Change in Aortic Valve Calcium (AVC) Score at 24 months

InterventionalRandomizedquadruple238 targetStarted 2026-08Completion 2029-11West China Hospital

A Randomized Controlled Trial of the Soluble Guanylate Cyclase Stimulator Vericiguat in Patients With Breast Cancer and Cancer Therapy-Related Cardiac Dysfunction (ELEVATE)

NCT05806138Registry updated 2026-08-03·Phase 2
Active, not recruiting

Primary endpoint: change in CRF (measured by VO2peak)

InterventionalRandomizedopen21 enrolledStarted 2023-07Completion 2028-071 site · United StatesMemorial Sloan Kettering Cancer Center

A Phase 2/3 Randomized, Placebo-Controlled, Double-blind, Clinical Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Systemic Left Ventricular Systolic Dysfunction (VALOR)

NCT05714085Registry updated 2026-08-28·Phase 2/Phase 3
Recruiting

Primary endpoint: Base Period: Change from baseline to Week 16 in N-terminal pro-brain natriuretic peptide (NT-proBNP)

InterventionalRandomizedquadruple342 targetStarted 2023-05Completion 2032-0450 sites · Belgium, Brazil, Canada, Colombia…Merck Sharp & Dohme LLC